[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100608729":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":19,"responsibleParty":35,"collaborators":7,"id":37,"slug":7,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":7,"eligibilityCriteria":42,"healthyVolunteers":38,"sex":43,"minAge":44,"maxAge":45,"enrollmentInfo":46,"targetDuration":7,"studyType":49,"phases":7,"briefSummary":50,"conditions":51,"keywords":7,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":62},{"fullName":5,"class":6},"HemoCept Inc.","INDUSTRY",null,[9],{"name":10,"affiliation":11,"role":12},"Jamie Doucet, MD","Boulder Heart","PRINCIPAL_INVESTIGATOR",[14],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Katharine Adkins","CONTACT","303-442-2395","kathari.adkins@bch.org",[20],{"facility":11,"status":21,"city":22,"state":23,"zip":24,"country":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"RECRUITING","Boulder","Colorado","80303","United States",{"type":27,"coordinates":28},"Point",[29,30],-105.27055,40.01499,{"lat":30,"lon":29},[33,34],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},{"name":10,"role":12,"phone":7,"phoneExt":7,"email":7},{"type":36,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100608729",false,"NCT07205341","Detecting Changes in Arterial Blood Volume and Cardiac Efficiency","A Pilot Clinical Study to Assess Correlation Between Arterial Blood Volume Status and Cardiac Efficiency, and HemoCept Device Data in Trans-Aortic Valve Replacement (TAVR} Surgery","Inclusion Criteria:\n\n* Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.\n* Subjects can be any gender but must be between (and including) the ages of 18 and 80.\n* Subject ls being treated by the participating healthcare facility .\n\n  ., Subject requires a trans-aortic valve replacement.\n* Subject is able and willing to provide informed consent and HIPM authorization.\n* Subject is able and willing to meet all study requirements.\n\nExclusion Criteria:\n\n* Subject is pregnant, breast-feeding, or intends to become pregnant during the course of the study.\n* Subject has a personal medical history that includes:\n\n  * Long O-T syndrome\n  * Cardiac channelopathies\n  * Seizures","ALL","18 Years","80 Years",{"count":47,"type":48},20,"ESTIMATED","OBSERVATIONAL","The objective of this Pilot Study is to demonstrate the efficacy of the Hemocept device in detecting changes in arterial blood volume and cardiac efficiency.",[52],"Aortic Valve Stenosis","2026-04-09",{"date":55,"type":56},"2026-04-13","ACTUAL",{"date":58,"type":56},"2025-04-29",{"date":60,"type":48},"2026-09",{"name":5,"class":6},1]